122 employees
Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.
2018
$130M
from 6 investors over 6 rounds
Day One Biopharmaceuticals raised $130M on February 10, 2021
Investors: Canaan, RA Capital Management, L.P., Viking Global Investors, Atlas Venture, Perceptive Advisors and T. Rowe Price